Report Categories
View AllRecent Articles
View All
Eli Lilly and Company LLY Announces 23B Planned Acquisition of Ajax Therapeutics to Bolster Hematological Oncology Pipeline
What Versamet VMET said about inventory management Q4 2025 Earnings Beat Estimates
What Korro Bio KRRO management is not saying enough about Technical Strength 20260506
OXSQ Oxford posts narrow Q4 2025 EPS miss shares dip 053 on mild negative investor sentiment